Drugs prescribed off-label may do more harm than good
A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help breathlessness in patients with respiratory disease – and may cause side…
Related Articles
Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD,…
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Nature Reviews Clinical Oncology – Third-generation EGFR tyrosine-kinase inhibitors (TKIs) are the standard-of-care first-line treatment for patients with advanced-stage EGFR-mutant NSCLC and their…
Semaglutide Rocketing Past Statins as Millions Eligible
A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
66th ASH Annual Meeting: Chasing Zebras: Navigating Rare Myeloid Neoplasms
Description: It turns out the old adage from our medical school days, “If you hear hoofbeats, think of horses, not zebras,” was not completely correct!…
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial
This large, randomised, placebo-controlled, double-blind, clinical trial showed no effect of the traditional Chinese medicine herbal compound FYTF-919 on functional recovery, survival, and health-related quality…
HLH: diagnostics revisited and improved
In this issue of Blood, Henter et al report on the updated hemophagocytic lymphohistiocytosis (HLH)-2004 diagnostic criteria for primary or familial hemoph
A new moonshot initiative to fight cervical cancer in the Indo-Pacific region is missing something
The Quad Cancer Moonshot Initiative to fight cervical cancer in the Indo-Pacific region is admirable, but three of the four partners aren’t practicing what they…
Early T2D Diagnosis Heightens Risks for Complications, Death
Those diagnosed with type 2 diabetes when younger than 40 years of age had greater risks for several diabetes-related outcomes.
Welcome to Own Your Labs – Own Your Labs
Click Here to Get Started Hello everyone – welcome to Own Your Labs We’ve long been getting our blood testing a bit cheaper than most through…
Same Drug, 2,200 Different Prices
Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.
